CD4 and COVID-19: This phenomenon may be responsible for a milder or asymptomatic course of SARS‐CoV‐2 infection in this population.[17] Cellular immunity analysis revealed that 40–60% of unexposed individuals and 100% of COVID‐19 convalescents had CD4+ T lymphocytes reactive to SARS‐CoV‐2.